As part of the PRO-LONG consortium, “Development and acceleration of innovative therapies for rare lung diseases”, funded by Health Holland, we are thrilled to welcome Ingvi as a PhD student, working with both our team and the Kapitein lab at Utrecht University.
Ingvi brings a multidisciplinary background spanning bioengineering, molecular biology, advanced microscopy, and microfluidics. His expertise will strengthen our efforts to expand the applications of ExM while advancing our engineering and automation platforms. We look forward to the innovations and collaborations that will emerge from his work within the consortium!
